Welcome & Opening Remarks

Olympios Papadimitriou, President, Hellenic Association of Pharmaceutical Companies (SFEE)
Download the presentation

“HTA Cooperation in the EU: Challenges and Opportunities”

Flora Giorgio, Head of Sector, Health Technology Assessment, Directorate General for Health and Food Safety (DG SANTE), European Commission, Brussels, Belgium
Download the presentation

“What is the Present-Day State of the Interface between HTA, Clinical Value, Regulation and Health Policy Making?”

Marcus Guardian, Chief Operating Officer, EUnetHTA Joint Action
Download the presentation

“The Evolving Approach to Medicines Value Assessment in European Markets”

Panos Kanavos, PhD, Associate Professor, Deputy Director, LSE Health, Department of Social Policy, London School of Economics
Download the presentation

“The Value of HTA as a Means of Managing Expenditure and Ensuring Investment”

Katarzyna Kolasa, PhD, Professor of Health Economics Kozminski University, Head of Health Economics and Healthcare Management Department, Principal Senior Consultant, Market Access HEOR Straub Medical, Wangs Switzerland
Download the presentation

“Key Access Challenges in the Greek Healthcare System”

Elena Chouliara, Secretary of PhRMA Innovation Forum, President & Managing Director ΑstraZeneca Greece & Cyprus
Download the presentation

“Negotiation Challenges for a Sustainable Net Price”

Yannis Dimarakis, Managing Partner, Scotwork
Download the presentation

“Issues Implementing HTA in Greece”

Antonis Karokis, External Affairs Director, MSD
Download the presentation

“Best Practices (do’s and don’t’s) for effective HTA”

Jaime Espin, Ph. Professor, Andalusian School of Public Health, Spain
Download the presentation

“The importance of Patient Preferences in HTA”

Eugena Stamuli, Founder, PharmEcons Easy Access Ltd
Download the presentation

The Way Forward for HTA Cooperation in Greece

Dimitris Pantazis, CEO, Institute of Pharmaceutical Research & Technology (IFET)
Download the presentation

“The importance of Epidemiologic Indicators in HTA”

Theoklis Zaoutis, MD, MSCE, PhD, Professor of Pediatrics and Epidemiology, Perelman School of Medicine Director of the postgraduate program of Clinical Epidemiology, University of Pennsylvania (UPENN), Chief of the Infectious Diseases Division of the Children’s Hospital of Philadelphia (CHOP)
Download the presentation